These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 37055095)

  • 41. New-onset dermatomyositis following COVID-19: A case report.
    Shimizu H; Matsumoto H; Sasajima T; Suzuki T; Okubo Y; Fujita Y; Temmoku J; Yoshida S; Asano T; Ohira H; Ejiri Y; Migita K
    Front Immunol; 2022; 13():1002329. PubMed ID: 36353621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination.
    Amiya S; Fujimoto J; Matsumoto K; Yamamoto M; Yamamoto Y; Yoneda M; Kuge T; Miyake K; Shiroyama T; Hirata H; Takeda Y; Kumanogoh A
    Int J Infect Dis; 2022 Mar; 116():255-257. PubMed ID: 35065256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
    Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR
    Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequelae of COVID-19 pneumonia: Is it correct to label everything as post-COVID lung fibrosis?
    Garg M; Maralakunte M; Dhooria S
    J Postgrad Med; 2021; 67(4):224-227. PubMed ID: 34845890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19 vaccine induced interstitial lung disease.
    Yoshifuji A; Ishioka K; Masuzawa Y; Suda S; Murata S; Uwamino Y; Fujino M; Miyahara H; Hasegawa N; Ryuzaki M; Hoshino H; Sekine K
    J Infect Chemother; 2022 Jan; 28(1):95-98. PubMed ID: 34580010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central and effector memory T cells in peripheral blood of patients with interstitial pneumonia: preliminary clues from a COVID-19 study.
    Bekbossynova M; Akhmaltdinova L; Dossybayeva K; Tauekelova A; Smagulova Z; Tsechoeva T; Turebayeva G; Sailybayeva A; Kalila Z; Mirashirova T; Muratov T; Poddighe D
    Respir Res; 2022 Oct; 23(1):278. PubMed ID: 36217141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [SARS-CoV-2-Infection and Interstitial Lung Disease: Position paper of the German Respiratory Society].
    Behr J; Berger M; Blum TG; Bonella F; Dinkel J; Gläser S; Hagmeyer L; Kneidinger N; Koschel D; Prasse A; Slevogt H; Stacher-Priehse E; Woehrle H; Kreuter M
    Pneumologie; 2023 Mar; 77(3):143-157. PubMed ID: 36918016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perpetually Positive: Post-COVID Interstitial Lung Disease in an Immunocompromised Patient With Diffuse Large B-cell Lymphoma.
    Dayco JS; El-Reda Z; Sumbal N; Alhusain R; Raheem S
    J Investig Med High Impact Case Rep; 2021; 9():23247096211041207. PubMed ID: 34427155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term side effects and lingering symptoms post COVID-19 recovery.
    Zarei M; Bose D; Nouri-Vaskeh M; Tajiknia V; Zand R; Ghasemi M
    Rev Med Virol; 2022 May; 32(3):e2289. PubMed ID: 34499784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Respiratory follow-up of patients with COVID-19 pneumonia.
    George PM; Barratt SL; Condliffe R; Desai SR; Devaraj A; Forrest I; Gibbons MA; Hart N; Jenkins RG; McAuley DF; Patel BV; Thwaite E; Spencer LG
    Thorax; 2020 Nov; 75(11):1009-1016. PubMed ID: 32839287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer.
    Catania C; Stati V; Spitaleri G
    Tumori; 2021 Jun; 107(3):267-269. PubMed ID: 32842909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations.
    Oldani S; Ravaglia C; Bensai S; Bertolovic L; Ghirotti C; Puglisi S; Martinello S; Sultani F; Colinelli C; Piciucchi S; Simoncelli S; Poletti V
    Pulmonology; 2022; 28(5):333-344. PubMed ID: 33832850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Omicron variants of SARS-CoV-2 and long COVID.
    Yang C; Zhao H; Shannon CP; Tebbutt SJ
    Front Immunol; 2022; 13():1061686. PubMed ID: 36569883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.
    Adler L; Gazit S; Pinto Y; Perez G; Mizrahi Reuveni M; Yehoshua I; Hoffman R; Azuri J; Patalon T
    Scand J Prim Health Care; 2022 Sep; 40(3):342-349. PubMed ID: 36314555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long COVID: An inevitable sequela of SARS-CoV-2 infection.
    Lai CC; Hsu CK; Yen MY; Lee PI; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2023 Feb; 56(1):1-9. PubMed ID: 36283919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SARS-CoV-2 as a causative agent of idiopathic interstitial pneumonia and interstitial pneumonia associated with collagen vascular disorders.
    Fujita J
    Respir Investig; 2020 Nov; 58(6):427-429. PubMed ID: 33032954
    [No Abstract]   [Full Text] [Related]  

  • 60. Acute Exacerbation of Interstitial Lung Disease as a Sequela of COVID-19 Pneumonia.
    Fonseca M; Summer R; Roman J
    Am J Med Sci; 2021 Jan; 361(1):126-129. PubMed ID: 32912600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.